BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27265131)

  • 1. Heterodimer HLA-DM Fused with Constant Fragment of the Heavy Chain of the Human Immunoglobulin Accelerates Influenza Hemagglutinin HA306-318 Loading to HLA-DR1.
    Mamedov AE; Ponomarenko NA; Belogurov AA; Gabibov AG
    Bull Exp Biol Med; 2016 May; 161(1):92-5. PubMed ID: 27265131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum to: Heterodimer HLA-DM Fused with Constant Fragment of the Heavy Chain of the Human Immunoglobulin Accelerates Influenza Hemagglutinin Peptide HA
    Mamedov AE; Ponomarenko NA; Belogurov AA; Gabibov AG
    Bull Exp Biol Med; 2016 Jul; 161(3):442-446. PubMed ID: 27520960
    [No Abstract]   [Full Text] [Related]  

  • 3. Stabilization of soluble, low-affinity HLA-DM/HLA-DR1 complexes by leucine zippers.
    Busch R; Pashine A; Garcia KC; Mellins ED
    J Immunol Methods; 2002 May; 263(1-2):111-21. PubMed ID: 12009208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetic basis of peptide exchange catalysis by HLA-DM.
    Zarutskie JA; Busch R; Zavala-Ruiz Z; Rushe M; Mellins ED; Stern LJ
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12450-5. PubMed ID: 11606721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain.
    Stratikos E; Wiley DC; Stern LJ
    J Immunol; 2004 Jan; 172(2):1109-17. PubMed ID: 14707085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the nature of the H-bonds between the human class II MHC protein, HLA-DR1 (DRB*0101) and the influenza virus hemagglutinin peptide, HA306-318, using the quantum theory of atoms in molecules.
    Aray Y; Aguilera-GarcĂ­a R; Izquierdo DR
    J Biomol Struct Dyn; 2019 Jan; 37(1):48-64. PubMed ID: 29246090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1.
    Natarajan SK; Stern LJ; Sadegh-Nasseri S
    J Immunol; 1999 Mar; 162(6):3463-70. PubMed ID: 10092802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: TCR contacts as anchors: effects on affinity and HLA-DM stability.
    Anderson MW; Gorski J
    J Immunol; 2003 Dec; 171(11):5683-7. PubMed ID: 14634075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct intracellular compartments involved in invariant chain degradation and antigenic peptide loading of major histocompatibility complex (MHC) class II molecules.
    Ferrari G; Knight AM; Watts C; Pieters J
    J Cell Biol; 1997 Dec; 139(6):1433-46. PubMed ID: 9396749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
    Li X; Li R; Li Z
    Tissue Antigens; 2006 Jan; 67(1):45-52. PubMed ID: 16451200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptides.
    Moro M; Cecconi V; Martinoli C; Dallegno E; Giabbai B; Degano M; Glaichenhaus N; Protti MP; Dellabona P; Casorati G
    BMC Immunol; 2005 Dec; 6():24. PubMed ID: 16329759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes.
    Zhou Z; Callaway KA; Weber DA; Jensen PE
    J Immunol; 2009 Oct; 183(7):4187-91. PubMed ID: 19767569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
    Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
    J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
    Schulze MS; Anders AK; Sethi DK; Call MJ
    PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
    Ghosh P; Amaya M; Mellins E; Wiley DC
    Nature; 1995 Nov; 378(6556):457-62. PubMed ID: 7477400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond.
    Ferrante A; Gorski J
    J Immunol; 2010 Feb; 184(3):1153-8. PubMed ID: 20038641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation of influenza hemagglutinin peptide in the presence of limited allostimulation by HLA-DR1 transfected human fibroblasts.
    Eckels DD; Sell TW; Long EO; Sekaly RP
    Hum Immunol; 1988 Mar; 21(3):173-81. PubMed ID: 2453491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.
    Stratikos E; Mosyak L; Zaller DM; Wiley DC
    J Exp Med; 2002 Jul; 196(2):173-83. PubMed ID: 12119342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.